PRESTIGE

PREvention of Late Stent Thrombosis by an Interdisciplinary Global European effort

 Coordinatore DEUTSCHES HERZZENTRUM MUNCHEN 

 Organization address address: Lazarettstrasse 36
city: MUNICH
postcode: 80636

contact info
Titolo: Mr.
Nome: Per
Cognome: Larsen
Email: send email
Telefono: +49 89 1218 1791
Fax: +49 89 1218 4083

 Nazionalità Coordinatore Germany [DE]
 Sito del progetto http://www.prestige-fp7.eu/index.php?id=267
 Totale costo 7˙981˙609 €
 EC contributo 5˙979˙641 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2010-single-stage
 Funding Scheme CP-FP
 Anno di inizio 2010
 Periodo (anno-mese-giorno) 2010-12-01   -   2014-11-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    DEUTSCHES HERZZENTRUM MUNCHEN

 Organization address address: Lazarettstrasse 36
city: MUNICH
postcode: 80636

contact info
Titolo: Mr.
Nome: Per
Cognome: Larsen
Email: send email
Telefono: +49 89 1218 1791
Fax: +49 89 1218 4083

DE (MUNICH) coordinator 1˙182˙400.00
2    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

 Organization address address: 101 Rue de Tolbiac
city: PARIS
postcode: 75654

contact info
Titolo: Ms.
Nome: Dina
Cognome: Falkenreck
Email: send email
Telefono: +33 1 43 62 27 19
Fax: +33 1 43 62 27 01

FR (PARIS) participant 990˙356.00
3    KATHOLIEKE UNIVERSITEIT LEUVEN

 Organization address address: Oude Markt 13
city: LEUVEN
postcode: 3000

contact info
Titolo: Prof.
Nome: Walter
Cognome: Desmet
Email: send email
Telefono: 3216343484
Fax: +32 16 342463

BE (LEUVEN) participant 711˙270.00
4    UNIVERSITY OF LEICESTER

 Organization address address: University Road
city: LEICESTER
postcode: LE1 7RH

contact info
Titolo: Mr.
Nome: Bikramjeet
Cognome: Singh
Email: send email
Telefono: 441163000000
Fax: 441163000000

UK (LEICESTER) participant 669˙364.00
5    AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII

 Organization address address: PIAZZA OMS 1
city: BERGAMO
postcode: 24127

contact info
Titolo: Dr.
Nome: Giulio
Cognome: Guagliumi
Email: send email
Telefono: +39 035 2652890
Fax: +39 035 400491

IT (BERGAMO) participant 454˙210.00
6    BIOTRONIK SE & CO. KG

 Organization address address: WOERMANNKEHRE 1
city: BERLIN
postcode: 12359

contact info
Titolo: Dr.
Nome: Alexander
Cognome: Rzany
Email: send email
Telefono: +49 9131 8924 7710
Fax: +49 9131 852 5631

DE (BERLIN) participant 380˙980.00
7    STICHTING SINT ANTONIUS ZIEKENHUIS

 Organization address address: KOEKOEKSLAAN 1
city: NIEUWEGEIN
postcode: 3435 CM

contact info
Titolo: Dr.
Nome: Jurrien Maria
Cognome: Ten Berg
Email: send email
Telefono: +31 30 6099111
Fax: +31 30 6034420

NL (NIEUWEGEIN) participant 371˙620.00
8    NEOPLAS GMBH

 Organization address address: WALTHER-RATHENAU-STRASSE 49A
city: GREIFSWALD
postcode: 17489

contact info
Titolo: Ms.
Nome: Renate
Cognome: Schönebeck
Email: send email
Telefono: +49 3834 515 210
Fax: +49 3834 515 210

DE (GREIFSWALD) participant 360˙980.00
9    HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH

 Organization address address: Ingolstaedter Landstrasse 1
city: MUENCHEN
postcode: 85764

contact info
Titolo: Dr.
Nome: Juergen
Cognome: Ertel
Email: send email
Telefono: +49 89 3187 3022
Fax: +49 89 3187 3866

DE (MUENCHEN) participant 346˙466.50
10    SERVICIO MADRILENO DE SALUD

 Organization address address: PLAZA CARLOS TRIAS BERTRAN 7
city: MADRID
postcode: 28020

contact info
Titolo: Dr.
Nome: Fernando
Cognome: Alfonso
Email: send email
Telefono: +34 915202476
Fax: +34 915202560

ES (MADRID) participant 121˙440.00
11    BENEDIKT-KREUTZ REHABILITATIONSZENTRUM FUER HERZ- UND KREISLAUFKRANKE BAD KROZINGEN EV

 Organization address address: Suedring 15
city: Bad Krozingen
postcode: 79189

contact info
Titolo: Dr.
Nome: Christian
Cognome: Valina
Email: send email
Telefono: +49 7633 402 2005
Fax: +49 7633 402 2009

DE (Bad Krozingen) participant 121˙200.00
12    KITOZYME SA

 Organization address address: RUE HAUTE CLAIRE PARC INDUSTRIEL 4
city: HERSTAL
postcode: 4040

contact info
Titolo: Ms.
Nome: Marie
Cognome: Hobe
Email: send email
Telefono: +32 4 2598500
Fax: +32 4 2598509

BE (HERSTAL) participant 110˙400.00
13    RIGAS TEHNISKA UNIVERSITATE

 Organization address address: KALKU IELA 1
city: RIGA
postcode: 1658

contact info
Titolo: Dr.
Nome: Garry
Cognome: Kerch
Email: send email
Telefono: 37129276942
Fax: 37167576942

LV (RIGA) participant 100˙755.00
14    Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie

 Organization address address: Kopernika 36
city: Krakow
postcode: 31-501

contact info
Titolo: Prof.
Nome: Dariusz
Cognome: Dudek
Email: send email
Telefono: 48124247181
Fax: 48124247184

PL (Krakow) participant 58˙200.00
15    UNIVERSITATS-HERZZENTRUM FREIBURG-BAD KROZINGEN GMBH

 Organization address address: SUDRING 15
city: BAD KROZINGEN
postcode: 79189

contact info
Titolo: Mr.
Nome: Gerhard
Cognome: Henninger
Email: send email
Telefono: +49 761270 19200
Fax: +49 761270 18890

DE (BAD KROZINGEN) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

treatment    stenting    issue    intervention    impact    late    coronary    disease    percutaneous    prediction    rate    thrombosis    health    artery    stent    strategies    years    significant    risk    prevention   

 Obiettivo del progetto (Objective)

'According to the European Society of Cardiology there has been an increase in the life expectancy at the age of 65 of the European population from 15.0 to 17.0 years in the years since 1980. In the elderly, up to 50% of deaths are caused by cardiovascular diseases, the majority accounted for by coronary artery disease. The most effective treatment for obstructive coronary disease is percutaneous intervention with coronary stenting and fuelled by the increasing disease burden there has been a rapid increase in the number of percutaneous coronary intervention procedures in Europe from 184,000 in 1992 to 885,000 in 2004. If the rate of progression remains constant, the projected number of coronary intervention procedures per annum will be about 1.5 million by 2010, with a stenting rate of close to 100%. The principal safety issue with current coronary stenting procedures is late stent thrombosis which, with a case mortality rate approaching 50%, makes this problem a very significant European health issue. The PRESTIGE project will result in significant improvement in prediction and prevention of late stent thrombosis by providing novel strategies that causally impede incident events without increasing the overall risk of bleeding. These goals will be achieved by a multidisciplinary consortium formed by world-leading EU-based specialists covering the requisite scientific skills and experience. Since the first drug-eluting stent was introduced in 2002 the growth of this sector has been explosive. Forecasts predicted the potential for this market segment to exceed €4.6 billion by 2009. The economic impact of this very ambitious project will be to provide the European health industries with novel stent products and new imaging technologies to identify patients at-risk, as well as amended European treatment guidelines. The social impact will be, amongst others, a tremendous cost reduction for the public and private health insurance systems all over Europe.'

Introduzione (Teaser)

Coronary stents are one of the most effective treatments for coronary artery disease. However, new strategies have to be implemented for better prediction and prevention of post-operative stent thrombosis.

Altri progetti dello stesso programma (FP7-HEALTH)

INYVAX (2009)

"Optimisation of the development of Poverty-Related-Diseases (PRD) vaccines by a transversal approach, addressing common gaps and challenges."

Read More  

BIOMARGIN (2013)

Biomarkers of renal graft injuries in kidney allograft recipients

Read More  

TRANSEURO (2010)

NEURAL TRANSPLANTATION IN THE TREATMENT OF PATIENTS WITH PARKINSON’S DISEASE

Read More